LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 7.01 | 17.25 | 808 | 389 | 2.0745 | 1.3524 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 8.98 | 17.25 | 1 | 445 | 0.0022 | -0.4552 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 8.98 | 17.25 | 725 | 445 | 1.6290 | 1.2193 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 8.98 | 17.25 | 27 | 445 | 0.0607 | 0.1002 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 8.98 | 17.25 | 854 | 445 | 1.9188 | 1.2982 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 10.95 | 17.25 | 1 | 471 | 0.0021 | -0.4494 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 10.95 | 17.25 | 750 | 471 | 1.5904 | 1.2042 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 10.95 | 17.25 | 36 | 471 | 0.0763 | 0.1666 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 10.95 | 17.25 | 889 | 471 | 1.8852 | 1.2841 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 12.91 | 17.25 | 1 | 494 | 0.0020 | -0.4446 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 12.91 | 17.25 | 756 | 494 | 1.5277 | 1.1829 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 12.91 | 17.25 | 66 | 494 | 0.1334 | 0.3193 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 12.91 | 17.25 | 889 | 494 | 1.7965 | 1.2572 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 14.88 | 17.25 | 2 | 534 | 0.0037 | -0.3528 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 14.88 | 17.25 | 759 | 534 | 1.4202 | 1.1468 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 14.88 | 17.25 | 95 | 534 | 0.1778 | 0.4112 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 14.88 | 17.25 | 895 | 534 | 1.6747 | 1.2194 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 16.85 | 17.25 | 10 | 655 | 0.0153 | -0.0987 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 16.85 | 17.25 | 768 | 655 | 1.1715 | 1.0612 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 16.85 | 17.25 | 272 | 655 | 0.4149 | 0.6913 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 16.85 | 17.25 | 905 | 655 | 1.3805 | 1.1267 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 18.82 | 17.25 | 7 | 800 | 0.0087 | -0.1504 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 18.82 | 17.25 | 774 | 800 | 0.9669 | 0.9879 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 18.82 | 17.25 | 358 | 800 | 0.4472 | 0.7294 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 18.82 | 17.25 | 909 | 800 | 1.1355 | 1.0465 | MN20160310_N02 | N03 |